The Prohost Biotechnology Fax/email Letter provides analysis of major breaking news
stories on the biotechnology companies, the drugs to be approved and the near and long
term stock price. Published 48 times per year, it is an invaluable resource for anyone
investing in the stock market and it is the ideal compliment to the original Prohost
Newsletter of Biotechnology Insight and Investment in print.
To subscribe to the Fax / Email Letter, Click here. You
will be given the option of subscribing for the Fax
Letter or email letter.
If you are already a Fax Letter subscriber and
would like to
receive the Fax
Letter via email instead of traditional fax, Click
here.
|
Click for subscription info
|
